Home
|
About Us
|
Team
|
Portfolio
|
News & Publications
|
Entrepreneurs
|
Community
|
Contact Us
News
Publications
News
Recent
|
2008
|
2007
|
2006
|
May. 6, 2009
Apexum receives FDA 510(k) clearance to market its Apexum Ablator device
Mar. 25, 2009
Incentive - Peregrine's Technological Incubator awarded Best Incubator of 2008 and Valtech Cardio Ltd. (a Peregrine portfolio company) awarded Best Company of 2008
Mar. 1, 2009
Apexum’s article was selected to feature on the cover page of the February 2009 issue of the Journal of Endodontics
Nov. 12, 2008
CA Acquires Eurekify, a Peregrine portfolio company
Sep. 9, 2008
Neovasc Expands Senior Management Team with New Positions in Marketing and Sales
Jul. 15, 2008
David Bird, Internationally Acclaimed Geophysicist, Joins Geomage as Executive Vice President, North America.
Jul. 2, 2008
NEWS FLASH; B-Balloon Ltd, Neovasc Medical Ltd & Medical Ventures Corp. Merge to Form New Company, Neovasc Inc (TSXV:NVC).
Jun. 26, 2008
Pallasium Ltd. Awarded Prestigious Frost & Sullivan, 2008 European WiMAX Capacity Enhancement Technology Innovation of the Year Award.
May. 28, 2008
Peregrine II Fund Invests in Eurekify Ltd.
May. 21, 2008
Peregrine Ventures E-News Alert, Quarter I/2008.
May. 20, 2008
NEWS FLASH; Cellvine Ltd. Signs Definative Merger Agreement with U.S Based Wi-tron, Inc. (OTCBB: WTRO).
May. 18, 2008
Apexum Ltd. Features In Israel21c, a Focus Beyond.
May. 14, 2008
CA, Eurekify Team to provide Fast Time-to-Value in Identity Management Deployments.
May. 12, 2008
Valtech Cardio Ltd. conducts successful pre-clinical trial of EZ-RING.
May. 7, 2008
Dr. Ken Larner, Leading Authority on Seismic Data Acquisition, Processing, and Interpretation, Joins Geomage Executive Advisory Board.
Mar. 18, 2008
Cellvine Ltd. Signs Distribution Agreement with Tessco Technologies Inc. (Nasdaq:TESS).
Mar. 18, 2008
Visionsense Corp. Announces FDA 510 (K) Clearance for New VSII System.
Mar. 18, 2008
Apexum Ltd. Completes Recruitment and Treatment of 100 Clinical Study Patients.
© Peregrine Ventures |
Terms & Conditions
|
Privacy Policy
Back to Top
